Glenmark Pharma gets USFDA nod for generic version of Loestrin 24 Fe Tablets

Glenmark logo


Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for HAILEY 24 Fe(Norethindrone Acetate and Ethinyl Estradiol Tablets, USP and Ferrous Fumarate Tablets), 1 mg/20 mcg, the generic version of Loestrin 24 Fe Tablets, of Allergan Pharmaceuticals International Ltd.

According to IQVIA sales data for the 12 month period ending September 2017, the Loestrin 24 Fe Tablets market achieved annual sales of approximately $96.7 million*.

Glenmark’s current portfolio consists of 128 products authorized for distribution in the U.S. marketplace and 59 ANDA’s pending approval with the U.S. FDA.

Yash Ved
Yash Ved is a Senior Correspondent at NewsBarons and comes with a decade of experience across leading online and offline publications. A keen observer of the stock index movement, Yash also likes covering Real Estate and the BFSI sector. A financial management and Journalism student, Yash believes learning as a continuous journey and enjoys following the IT and the Pharmaceutical industry and has penned many articles on the subjects.